2024
DOI: 10.3390/nu16050736
|View full text |Cite
|
Sign up to set email alerts
|

Proteomic Profiling of Plasma- and Gut-Derived Extracellular Vesicles in Obesity

Pedro Baptista Pereira,
Estefania Torrejón,
Inês Ferreira
et al.

Abstract: Obesity entails metabolic alterations across multiple organs, highlighting the role of inter-organ communication in its pathogenesis. Extracellular vesicles (EVs) are communication agents in physiological and pathological conditions, and although they have been associated with obesity comorbidities, their protein cargo in this context remains largely unknown. To decipher the messages encapsulated in EVs, we isolated plasma-derived EVs from a diet-induced obese murine model. Obese plasma EVs exhibited a decline… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 103 publications
0
1
0
Order By: Relevance
“…Another study has shown that transforming growth factor beta 1 (TGFBI) in circulating EVs may facilitate monitoring the T2D status in obese patients, and EV-mimecan (aka osteoglycin) may be useful to track visceral obesity [7]. Proteomics analysis of exosomes from mouse plasma has revealed an upregulation of two proteins (immunoglobulins) and downregulation of 10 proteins (14-3-3 protein isoforms, proteasome subunits, and others) in mice with diet-induced obesity [8]. Proteomics analysis has also been performed in adipocytes of human subjects which revealed that changes in proteins related to lipid metabolism and unfolded protein response discriminate insulinresistant and insulin-sensitive individuals with unequal adiposity [9].…”
Section: Introductionmentioning
confidence: 99%
“…Another study has shown that transforming growth factor beta 1 (TGFBI) in circulating EVs may facilitate monitoring the T2D status in obese patients, and EV-mimecan (aka osteoglycin) may be useful to track visceral obesity [7]. Proteomics analysis of exosomes from mouse plasma has revealed an upregulation of two proteins (immunoglobulins) and downregulation of 10 proteins (14-3-3 protein isoforms, proteasome subunits, and others) in mice with diet-induced obesity [8]. Proteomics analysis has also been performed in adipocytes of human subjects which revealed that changes in proteins related to lipid metabolism and unfolded protein response discriminate insulinresistant and insulin-sensitive individuals with unequal adiposity [9].…”
Section: Introductionmentioning
confidence: 99%